129 related articles for article (PubMed ID: 37788128)
1. Effect of preoperative programmed death-1 or programmed death ligand-1 immune check point inhibition on complications after surgery for primary head and neck cancer.
Philips R; Alnemri A; Amin D; Patel J; Topf MC; Johnson JM; BarAd V; Axelrod R; Argiris A; Fundakowski C; Luginbuhl AJ; Cognetti DM; Curry JM
Cancer; 2024 Mar; 130(6):863-875. PubMed ID: 37788128
[TBL] [Abstract][Full Text] [Related]
2. Association of Neoadjuvant Pembrolizumab for Oral Cavity Squamous Cell Carcinoma With Adverse Events After Surgery in Treatment-Naive Patients.
Tang AL; O'Neil T; McDermott S; Tripathi S; Tikhtman R; Mark JR; Patil Y; Tabangin M; Altaye M; Wise-Draper TM; Zender CA
JAMA Otolaryngol Head Neck Surg; 2022 Oct; 148(10):935-939. PubMed ID: 36006622
[TBL] [Abstract][Full Text] [Related]
3. Treatment outcomes of transoral robotic and non-robotic surgeries to treat oropharyngeal, hypopharyngeal, and supraglottic squamous cell carcinoma: A multi-center retrospective observational study in Japan.
Sano D; Shimizu A; Tateya I; Fujiwara K; Mori T; Miyamoto S; Nishikawa D; Terada T; Yasumatsu R; Ueda T; Matsumoto F; Kishimoto Y; Maruo T; Fujimoto Y; Tsukahara K; Yoshimoto S; Nibu KI; Oridate N
Auris Nasus Larynx; 2021 Jun; 48(3):502-510. PubMed ID: 33632582
[TBL] [Abstract][Full Text] [Related]
4. Free flap head and neck reconstruction: Feasibility in older patients.
Parsemain A; Philouze P; Pradat P; Ceruse P; Fuchsmann C
J Geriatr Oncol; 2019 Jul; 10(4):577-583. PubMed ID: 30497979
[TBL] [Abstract][Full Text] [Related]
5. Comparative safety and effectiveness of transoral robotic surgery versus open surgery for oropharyngeal cancer: A systematic review and meta-analysis.
Park DA; Lee MJ; Kim SH; Lee SH
Eur J Surg Oncol; 2020 Apr; 46(4 Pt A):644-649. PubMed ID: 31627931
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the Relationship between Age and Outcome after Microvascular Reconstruction among Patients with Recurrent Head and Neck Squamous Cell Carcinoma.
Patel VM; Stern C; Miglani A; Weichman KE; Lin J; Ow TJ; Garfein ES
J Reconstr Microsurg; 2017 Jun; 33(5):336-342. PubMed ID: 28235217
[No Abstract] [Full Text] [Related]
7. Results of free flap reconstruction for patients aged 80 years or older with head and neck cancer.
Otsuki N; Furukawa T; Avinçsal MO; Teshima M; Shinomiya H; Oshikiri T; Nakamura T; Nomura T; Hashikawa K; Nibu KI
Auris Nasus Larynx; 2020 Feb; 47(1):123-127. PubMed ID: 31060883
[TBL] [Abstract][Full Text] [Related]
8. Reconstruction following transoral robotic surgery for head and neck cancer: Systematic review.
Barrette LX; De Ravin E; Carey RM; Mady LJ; Cannady SB; Brody RM
Head Neck; 2022 May; 44(5):1246-1254. PubMed ID: 35137993
[TBL] [Abstract][Full Text] [Related]
9. Complications, Mortality, and Functional Decline in Patients 80 Years or Older Undergoing Major Head and Neck Ablation and Reconstruction.
Fancy T; Huang AT; Kass JI; Lamarre ED; Tassone P; Mantravadi AV; Alwani MM; Subbarayan RS; Bur AM; Worley ML; Graboyes EM; McMullen CP; Azoulay O; Wax MK; Cave TB; Al-Khudari S; Abello EH; Higgins KM; Ryan JT; Orzell SC; Goldman RA; Vimawala S; Fernandes RP; Abdelmalik M; Rajasekaran K; L'Esperance HE; Kallogjeri D; Rich JT
JAMA Otolaryngol Head Neck Surg; 2019 Dec; 145(12):1150-1157. PubMed ID: 31600390
[TBL] [Abstract][Full Text] [Related]
10. An experience on primary thinning and secondary debulking of anterolateral thigh flap in head and neck reconstruction.
Cigna E; Minni A; Barbaro M; Attanasio G; Sorvillo V; Malzone G; Chen HC; Ribuffo D
Eur Rev Med Pharmacol Sci; 2012 Aug; 16(8):1095-101. PubMed ID: 22913160
[TBL] [Abstract][Full Text] [Related]
11. Transoral robotic surgery for management of cervical unknown primary squamous cell carcinoma: Updates on efficacy, surgical technique and margin status.
Geltzeiler M; Doerfler S; Turner M; Albergotti WG; Kubik M; Kim S; Ferris R; Duvvuri U
Oral Oncol; 2017 Mar; 66():9-13. PubMed ID: 28249654
[TBL] [Abstract][Full Text] [Related]
12. Six-year experience of microvascular free-flap reconstruction of head and neck neoplasms.
Olguín Joseau S; Arias A; Sánchez JC; Valle P; Garzón Bertola A; Peretti E; Guzmán L; Ruggieri M
Rev Fac Cien Med Univ Nac Cordoba; 2021 Dec; 78(4):335-339. PubMed ID: 34962745
[TBL] [Abstract][Full Text] [Related]
13. Identification of factors related to immunotherapy efficacy and prognosis in patients with advanced head and neck squamous cell carcinoma.
Xu X; Li R; Zhang L; Zhu G; Ren D; Wu L; Gong X
Diagn Pathol; 2021 Nov; 16(1):110. PubMed ID: 34823553
[TBL] [Abstract][Full Text] [Related]
14. Hypothyroidism in Head and Neck Squamous Cell Carcinoma Patients Receiving Radiotherapy With or Without Immune Checkpoint Inhibitors.
Leddon JL; Chirra M; Frankart AJ; Agrawal A; Roof L; Trotier D; Shaikh H; Stone T; Jandarov R; Takiar V; Wise-Draper TM
Laryngoscope; 2021 Jul; 131(7):E2413-E2419. PubMed ID: 33609046
[TBL] [Abstract][Full Text] [Related]
15. The impact of smoking on surgical complications after head and neck reconstructive surgery with a free vascularised tissue flap: a systematic review and meta-analysis.
Garip M; Van Dessel J; Grosjean L; Politis C; Bila M
Br J Oral Maxillofac Surg; 2021 Apr; 59(3):e79-e98. PubMed ID: 33546845
[TBL] [Abstract][Full Text] [Related]
16. Transoral robotic surgery in the management of head and neck squamous cell cancer with unknown primary.
Nilsson JS; Wahlberg P; Greiff L
Acta Otolaryngol; 2020 Jan; 140(1):85-88. PubMed ID: 31738643
[No Abstract] [Full Text] [Related]
17. Immediate Use of Uncuffed Tracheostomy after Free Flap Reconstruction of the Head and Neck.
Patel PN; Valmadrid AC; Hong DY; Francis DO; Sim MW; Rohde SL
Otolaryngol Head Neck Surg; 2018 Aug; 159(2):242-248. PubMed ID: 29664694
[TBL] [Abstract][Full Text] [Related]
18. Patterns of cervical node positivity, regional failure rates, and fistula rates for HPV+ oropharyngeal squamous cell carcinoma treated with transoral robotic surgery (TORS).
Cannon RB; Houlton JJ; Patel S; Raju S; Noble A; Futran ND; Parvathaneni U; Méndez E
Oral Oncol; 2018 Nov; 86():296-300. PubMed ID: 30409315
[TBL] [Abstract][Full Text] [Related]
19. Initial analysis of the synergy of programmed cell death-1 (PD-1) inhibitor and concurrent chemoradiotherapy treatment for recurrent/metastatic head and neck squamous cell carcinoma patients.
Li L; Chen L; Yan L; Guo Y; Li F; Fan M; Lan M; Lai X; Zhou J; Huang Y; Xu P; Lang J; Feng M
Radiat Oncol; 2023 Jul; 18(1):109. PubMed ID: 37403098
[TBL] [Abstract][Full Text] [Related]
20. Risk factors associated with postoperative complications of free anterolateral thigh flap placement in patients with head and neck cancer: Analysis of propensity score-matched cohorts.
Lin PC; Kuo PJ; Kuo SCH; Chien PC; Hsieh CH
Microsurgery; 2020 Jul; 40(5):538-544. PubMed ID: 32271497
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
